Brazilian Journal of Nephrology (Aug 2020)

Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function

  • José A. Moura-Neto,
  • Ana Maria Misael,
  • Dirceu Reis da Silva,
  • Ronaldo D’Avila,
  • Maria Claudia Cruz Andreoli,
  • Angiolina Kraychete,
  • Kleyton Bastos,
  • Marcelo Mazza do Nascimento

DOI
https://doi.org/10.1590/2175-8239-jbn-2020-s113
Journal volume & issue
Vol. 42, no. 2 suppl 1
pp. 49 – 50

Abstract

Read online Read online

ABSTRACT Chloroquine and hydroxychloroquine have shown promising preliminary results and have been discussed as therapeutic options for patients with Covid-19. Despite the lack of robust evidence demonstrating the benefits and justifying the use of one of these drugs, the final decision is the responsibility of the attending physician and should be individualized and shared, whenever possible. This position statement recommends dosage adjustment for these drugs in the context of renal impairment.

Keywords